JioStar

Reliance Industries Ltd. has finalized its merger with Jiostar, marking a strategic move that strengthens its footprint in advanced biotechnology, regenerative medicine, and stem-cell research. The consolidation integrates Jiostar’s scientific expertise with Reliance’s deep capital base and industrial scale, creating a platform geared toward cutting-edge therapies and biotech-driven healthcare innovation. The merged entity is expected to accelerate research, expand manufacturing capabilities, and drive commercialization of next-generation treatments.

JioStar, the newly formed media juggernaut from the merger of Reliance’s media division and Walt Disney’s India operations, has quickly become a dominant force in India’s entertainment ecosystem. In its inaugural earnings disclosure, the company reported Rs. 10,006 crore in revenue and Rs. 774 crore in pre-tax earnings. Its flagship streaming service, JioHotstar—launched in February 2025—crossed 100 million paid subscribers within five weeks.